Rosacea treatment update: recommendations from the global ROS acea CO nsensus ( ROSCO ) panel
Autor: | Martin Schaller, Martin Steinhoff, Bernard Cribier, Anthony Bewley, Hazel H Oon, Guy F. Webster, E.J. van Zuuren, G. Kautz, Y. Wu, L. M C Almeida, Mark J. Mannis, Ncoza C. Dlova, Murlidhar Rajagopalan, Jerry Tan, Patricia Troielli, Diane Thiboutot |
---|---|
Rok vydání: | 2017 |
Předmět: |
medicine.medical_specialty
Consensus Eye Diseases Alternative medicine MEDLINE Signs and symptoms Dermatology Ocular rosacea 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Pharmacotherapy Cosmeceuticals Humans Medicine 030212 general & internal medicine business.industry Skin Care medicine.disease Patient preference Surgery Patient management Treatment Outcome Rosacea Drug Therapy Combination Dermatologic Agents business Sunscreening Agents Algorithms |
Zdroj: | British Journal of Dermatology, 176(2), 465-471 |
ISSN: | 1365-2133 0007-0963 |
Popis: | SummaryBackground Rosacea is currently treated according to subtypes. As this does not adequately address the spectrum of clinical presentation (phenotypes), it has implications for patient management. The ROSacea COnsensus panel was established to address this issue. Objectives To incorporate current best treatment evidence with clinical experience from an international expert panel and establish consensus to improve outcomes for patients with rosacea. Methods Seventeen dermatologists and three ophthalmologists reached consensus on critical aspects of rosacea treatment and management using a modified Delphi approach. The panel voted on statements using the responses ‘strongly disagree’, ‘disagree’, ‘agree’ or ‘strongly agree’. Consensus was defined as ≥ 75% ‘agree’ or ‘strongly agree’. All voting was electronic and blinded. Results The panel agreed on phenotype-based treatments for signs and symptoms presenting in individuals with rosacea. First-line treatments were identified for individual major features of transient and persistent erythema, inflammatory papules/pustules, telangiectasia and phyma, underpinned by general skincare measures. Multiple features in an individual patient can be simultaneously treated with multiple agents. If treatment is inadequate given appropriate duration, another first-line option or the addition of another first-line agent should be considered. Maintenance treatment depends on treatment modality and patient preferences. Ophthalmological referral for all but the mildest ocular features should be considered. Lid hygiene and artificial tears in addition to medications are used to treat ocular rosacea. Conclusions Rosacea diagnosis and treatment should be based on clinical presentation. Consensus was achieved to support this approach for rosacea treatment strategies. |
Databáze: | OpenAIRE |
Externí odkaz: |